Showing results (121-130 of 649) with videos related to
Sort By:
Pageof 65
PPAR Research|April 8, 2017
Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive ConditionsYong-Jik Lee, Yoo-Na Jang, Yoon-Mi Han, et al.PPAR Research|March 22, 2017
Investigations on Binding Pattern of Kinase Inhibitors with PPARγ: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation StudiesMohit Mazumder, Prija Ponnan, Umashankar Das, et al.PPAR Research|January 28, 2017
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and FibrosisSi-Chi Xu, Zhen-Guo Ma, Wen-Ying Wei, et al.PPAR Research|January 25, 2017
Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and MinionsSalvatore Giovanni Vitale, Antonio Simone Laganà, Angela Nigro, et al.PPAR Research|October 5, 2016
PPARγ as a Novel Therapeutic Target in Lung CancerAravind T Reddy, Sowmya P Lakshmi, Raju C ReddyPPAR Research|May 13, 2014
Radix Astragali Improves Dysregulated Triglyceride Metabolism and Attenuates Macrophage Infiltration in Adipose Tissue in High-Fat Diet-Induced Obese Male Rats through Activating mTORC1-PPAR γ Signaling PathwayYang Long, Xiang-Xun Zhang, Tao Chen, et al.PPAR Research|May 13, 2014
Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord InjuryCheng-Chia Tsai, Kung-Shing Lee, Sheng-Hsien Chen, et al.PPAR Research|June 14, 2008
Screening for PPAR Responsive Regulatory Modules in CancerMerja Heinäniemi, Carsten CarlbergPPAR Research|June 14, 2008
Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer PathogenesisDavide Genini, Giuseppina M Carbone, Carlo V CatapanoPageof 65